FP7H2020HORIZON
Ustav Experimentalni Mediciny Akademie Ved Ceske Republiky Verejna Vyzkumna Instituce
- Country
- CZCzechia
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 2,424,520
- Active
- 2008 to 2023
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| PAREMPIParticle emission prevention and impact: from real-world emissions of traffic to secondary PM of urban air | HORIZON | 2023 | Participant | EUR 400,354 |
| ASTROTECHDisruptive materials, technologies & approaches to unravel the role of Astrocytes in brain function and dysfunction: towards to Glial interfaces | H2020 | 2020 | Participant | EUR 234,872 |
| iP-OSTEOInduced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds | H2020 | 2019 | Coordinator | EUR 257,600 |
| ActiTOXActive organotypic models for nanoparticle toxicological screening | H2020 | 2019 | Participant | EUR 105,800 |
| TUBETransport derived Ultrafines and the Brain Effects | H2020 | 2019 | Participant | EUR 337,772 |
| HBM4EUEuropean Human Biomonitoring Initiative | H2020 | 2017 | Third party | Not stated |
| TARGEARTargeting challenges of active ageing: innovative integrated strategies for the healing of age-related hearing loss | H2020 | 2014 | Participant | EUR 62,863 |
| NANOREGA common European approach to the regulatory testing of nanomaterials | FP7 | 2013 | Participant | EUR 16,000 |
| CITI-SENSEDevelopment of sensor-based Citizens' Observatory Community for improving quality of life in cities | FP7 | 2012 | Participant | EUR 314,000 |
| QUALITYNANOA pan-European infrastructure for quality in nanomaterials safety testing | FP7 | 2011 | Participant | EUR 12,198 |
| BIOSCENTBIOactive highly porous and injectable Scaffolds controlling stem cell recruitment, proliferation and differentiation and enabling angiogenesis for Cardiovascular ENgineered Tissues | FP7 | 2009 | Participant | EUR 159,760 |
| EDU-GLIAInnovative Techniques and Models to Study Glia-Neuron Interactions | FP7 | 2009 | Participant | EUR 183,044 |
| AXREGENAxonal regeneration, plasticity & stem cells | FP7 | 2008 | Participant | EUR 340,258 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.